Detection of BRCA1 and BRCA2 mutations in breast cancer families by a comprehensive two-stage screening procedure

International Journal of Cancer

Volumn 85, Issue 4, 2000, Pages 474-481

  Spitzer, Eva ^a   Abbaszadegan, Mohammad R ^b,f   Schmidt, Frank ^a   Hauser, Andrea ^a   Buwitt, Ute ^c   Lauter, Frank Roman ^c   Pötschick, Kathrin ^d   Krocker, Jutta ^e   Elling, Dirk ^e   Grosse, Richard ^a,g  

^a Inst of Med Molecular Diagnostics   (Germany)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c BioInside GmbH   (Germany)

^d Genetic Counseling Unit   (Germany)

^e Lichtenberg Hospital   (Germany)

^f MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g Inst fur Med M   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE;

ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER SCREENING; CANCER STAGING; GENE MUTATION; GENE SEQUENCE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL;

ADULT; AGE OF ONSET; AGED; BRCA2 PROTEIN; BREAST NEOPLASMS; EXONS; FAMILY; FEMALE; GENES, BRCA1; GENES, TUMOR SUPPRESSOR; GENETIC SCREENING; HUMANS; INTRONS; LOSS OF HETEROZYGOSITY; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; POINT MUTATION; SEQUENCE DELETION; TRANSCRIPTION FACTORS;

EID: 0033973251     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000215)85:4<474::AID-IJC5>3.0.CO;2-4     Document Type: Article

References (24)

1. ABBASZADEGAN, M.R., STRUEWING, J., BROWN, K.M., SNIDER, J., GORELANGTON, R. and HUGHES, M.R., Automated detection of highly prevalent mutations in BRCA1 and BRCA2 genes using a fluorogenic PCR. Genet. Testing, 1, 171-180 (1998).
2. BRODY, L.C. and BIESECKER, D.B., Breast cancer susceptibility genes. Medicine, 77, 208-226 (1998).
3. COUCH, F.J. and WEBER, B.L., Breast cancer information core: mutations and polymorphisms in the familial early-onset breast cancer BRCA1 gene. Hum. Mutation, 8, 8-18 (1996).
4. EISINGER, F., JACQUEMIER, J., CHARPIN, C., STOPPA-LYONNET, D., BRESSAC-DE PAILLERETS, B., PEYRAT, J.P., LONGY, M. and GUINEHBETIÉRE, J.-M., Mutations at BRCA1: the medullary breast carcinoma revisited. Cancer Res., 58, 1588-1592 (1998).
5. ELLISEN, L.W. and HABER, D.A., Hereditary breast cancer. Ann. Rev. Med., 49, 425-436 (1998).
6. GANGULY, A., LEALIY, K., MARSHALL, A., DHULIPALA, R., GODMILOW, L. and GANGULY, T., Genetic testing for breast cancer susceptibility: frequency of BRCA1 and BRCA2 mutations. Genet. Test., 1, 85-90 (1997).
7. GANGULY, A., ROCK, M.J. and PROCKOP, D.J., Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes. Proc nat. Acad. Sci. (Wash.), 90, 10325-10329 (1993).
8. GANGULY, T., DHULIPALA, R., GODMILOW, L. and GANGULY, A., High throughput fluorescence-based conformation sensitive gel electrophoresis (F-CSGE) identities six unique BRCA2 mutations and an overall low incidence of BRCA2 mutations in high-risk BRCA1-negative breast cancer families. Hum. Genet, 102, 549-556 (1998).
9. GLAVAC, D. and DEAN, M., Applications of heteroduplex analysis for mutation detection in disease genes. Hum. Mutation, 6, 281-287 (1995).
10. HOGERVORST, F.B. and 14 OTHERS, Rapid detection of BRCA1 mutations by the protein truncation test. Nature (Genet.), 10, 208-212 (1995).
11. JOHANNESDOTTIR, G., GUDMUNDSSON, J., BERGTHORSSON, J.T., ARASON, A. and BJARN, A., High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients. Cancer Res., 56, 3663-3665 (1996).
12. KÖRKKÖ, J., PIHLAJAMAA, T., PROCKOP, D.J. and ALA-KOKKO, L., Conformation sensitive gel electrophoresis for simple and accurate detection of mutations: comparison with denaturating gel electrophoresis and nucleotide sequencing. Proc. nat. Acad Sci. (Wash.), 95, 1681-1685 (1998).
13. LIVAK, K.J., MARMARO, J. and FLOOD, S., Guidelines for designing TaqMan fluorogenic probes for 5′ nuclease. ABI PRISM sequence detection systems. Research News. The Perkin-Elmer Corporation (1995a).
14. LIVAK, K.J., MARMARO, J. and TODD, J.A., Towards fully automated genome-wide polymorphism screening. Nature (Genet.), 9, 341-342 (1995b).
15. MARKOFF, A., SRMBROEN, H., BOGDANOVA, N., PREISLER-ADAMS, S., GAUEN, V., DWORNIZAK, B. and HORST, J., Comparison of conformation sensitive gel electrophoresis and single-strand conformation polymorphism analysis for detection of mutations in the BRCA1 gene using optimized conformation analysis protocols. Europ. J. Hum. Genet., 6, 145-150 (1998).
16. MARSHALL, R.D. and SKLAR. J., Protocol methods of mutation detection. Curr. Opin. Genet. Dev., 6, 275-280 (1996).
17. MEINDL, A., A BRCA1 and BRCA2 mutation profile for German breast and ovarian cancer families. The German consortium for hereditary breast and ovarian cancer. Mediz. Genet., 11, 120 (1999).
18. MIKI, Y. and 44 OTHERS, A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66-71 (1994).
19. OLSEN, J.H., SEERSHOLM, N., BOICE, J.D., KRÜGER-KAJER, S. and FRAUMENI, J.F., Cancer risk in close relatives of women with early-onset breast cancer - A population-based incidence study. Brit. J. Cancer, 79, 673-679 (1999).
20. RAHMAN, N. and STRATTON, M.R.,The genetics of breast cancer susceptibility. Ann. Rev. Genet., 32, 95-121 (1998).
21. ROA, B.B., BOYD, A.A., VOLCIK, K. and RICHARDS, C.S., Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nature (Genet.), 14, 185-187 (1996).
22. SHEFFIELD, V., COX, D., LERMAN, L.S. and MYERS, R.M., Attachment of a 40-base-pair G+C-rich sequence (GC clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes. Proc. nat. Acad. Sci. (Wash.), 86, 232-236 (1989).
23. SZABO, C.I. and KING, M.-C., Population genetics of BRCA1 and BRCA2. Amer. J. Hum. Genet., 60, 1013-1020 (1997).
24. WOOSTER, R. and 30 OTHERS, Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 12q12-13. Science, 265, 2088-2090 (1994).